http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021330950-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c965b76827e500120c872ebf22a51655
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2210-0693
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0009
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-0412
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2037-0007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-0504
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-327
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-40
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M37-00
filingDate 2021-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ec212fd5e22c624746a4802038ff979
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f1e84e8b33cbfb10f786c6f51bd1288d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a3adc0055ceca4d705e2c311cfeaab6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e2bdf6d43ffacfd38836ea3e28e91a6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d67a993f4f6019ab381b4047153afcbe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf2056eb78213480dc291acf26e79482
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0cd60d1031c5180db47e5cccd2a0af4b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f633baebc915a8337b023c217a5c356
publicationDate 2021-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2021330950-A1
titleOfInvention Using Alternating Electric Fields to Increase Permeability of the Blood Brain Barrier
abstract Many drugs and other molecules cannot ordinarily traverse the blood brain barrier (BBB). However, when alternating electric fields at certain optimum frequencies (e.g., 100 kHz) are applied to the brain, the BBB becomes permeable to those molecules. When the alternating electric fields are discontinued, the BBB eventually recovers to its original impermeable state. Subsequently, re-application of alternating electric fields at the optimum frequencies will re-open the BBB. Ordinarily, many frequencies (e.g., 200 kHz) of alternating electric fields are either ineffective or less effective at inducing permeability than the optimum frequencies. But once the BBB has been opened by applying alternating electric fields at the optimum frequencies, alternating electric fields at non-optimum frequencies can maintain the permeability of a previously-opened BBB.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11577076-B2
priorityDate 2020-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017281934-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014039489-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11400269-B2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396057
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID156646
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226669745
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36314

Total number of triples: 37.